Literature DB >> 33782037

A New View of Iron Management in Heart Failure: What Nephrologists Need to Know.

Nupur N Uppal1, Steven Fishbane2.   

Abstract

Entities:  

Keywords:  anemia iron; heart failure

Mesh:

Substances:

Year:  2021        PMID: 33782037      PMCID: PMC8092052          DOI: 10.2215/CJN.01850221

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  11 in total

1.  Impact of iron deficiency on exercise capacity and outcome in heart failure with reduced, mid-range and preserved ejection fraction.

Authors:  Pieter Martens; Petra Nijst; Frederik H Verbrugge; Kevin Smeets; Matthias Dupont; Wilfried Mullens
Journal:  Acta Cardiol       Date:  2017-07-21       Impact factor: 1.718

2.  Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula.

Authors:  Finlay A McAlister; Justin Ezekowitz; Luigi Tarantini; Iain Squire; Michel Komajda; Antoni Bayes-Genis; Israel Gotsman; Gillian Whalley; Nikki Earle; Katrina K Poppe; Robert N Doughty
Journal:  Circ Heart Fail       Date:  2012-03-22       Impact factor: 8.790

3.  Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis.

Authors:  Vojtech Melenovsky; Jiri Petrak; Tomas Mracek; Jan Benes; Barry A Borlaug; Hana Nuskova; Tomas Pluhacek; Jaroslav Spatenka; Jana Kovalcikova; Zdenek Drahota; Josef Kautzner; Jan Pirk; Josef Houstek
Journal:  Eur J Heart Fail       Date:  2016-09-19       Impact factor: 15.534

4.  Iron deficiency in chronic heart failure: an international pooled analysis.

Authors:  Ijsbrand T Klip; Josep Comin-Colet; Adriaan A Voors; Piotr Ponikowski; Cristina Enjuanes; Waldemar Banasiak; Dirk J Lok; Piotr Rosentryt; Ainhoa Torrens; Lech Polonski; Dirk J van Veldhuisen; Peter van der Meer; Ewa A Jankowska
Journal:  Am Heart J       Date:  2013-02-22       Impact factor: 4.749

5.  Epidemiology of chronic kidney disease in heart failure.

Authors:  Ali Ahmed; Ruth C Campbell
Journal:  Heart Fail Clin       Date:  2008-10       Impact factor: 3.179

6.  Ferric carboxymaltose in patients with heart failure and iron deficiency.

Authors:  Stefan D Anker; Josep Comin Colet; Gerasimos Filippatos; Ronnie Willenheimer; Kenneth Dickstein; Helmut Drexler; Thomas F Lüscher; Boris Bart; Waldemar Banasiak; Joanna Niegowska; Bridget-Anne Kirwan; Claudio Mori; Barbara von Eisenhart Rothe; Stuart J Pocock; Philip A Poole-Wilson; Piotr Ponikowski
Journal:  N Engl J Med       Date:  2009-11-17       Impact factor: 91.245

Review 7.  Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials.

Authors:  Ewa A Jankowska; Michał Tkaczyszyn; Tomasz Suchocki; Marcin Drozd; Stephan von Haehling; Wolfram Doehner; Waldemar Banasiak; Gerasimos Filippatos; Stefan D Anker; Piotr Ponikowski
Journal:  Eur J Heart Fail       Date:  2016-01-28       Impact factor: 15.534

8.  Heart Failure Hospitalization Risk associated with Iron Status in Veterans with CKD.

Authors:  Monique E Cho; Jared L Hansen; Brian C Sauer; Alfred K Cheung; Adhish Agarwal; Tom Greene
Journal:  Clin J Am Soc Nephrol       Date:  2021-03-29       Impact factor: 8.237

9.  Intravenous iron therapy for patients with heart failure: expanding body of evidence.

Authors:  Christopher Adlbrecht
Journal:  ESC Heart Fail       Date:  2019-07-16

10.  Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†.

Authors:  Piotr Ponikowski; Dirk J van Veldhuisen; Josep Comin-Colet; Georg Ertl; Michel Komajda; Viacheslav Mareev; Theresa McDonagh; Alexander Parkhomenko; Luigi Tavazzi; Victoria Levesque; Claudio Mori; Bernard Roubert; Gerasimos Filippatos; Frank Ruschitzka; Stefan D Anker
Journal:  Eur Heart J       Date:  2014-08-31       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.